FindTrial
Sign In

Comparison of intermittent use of a very low calorie diet (VLC) versus Orlistat for weight maintenance in the management of obese patients with type 2 diabetes

Comparison of intermittent use of a very low calorie diet (VLC) versus Orlistat for weight maintenance in the management of obese patients with type 2 diabetes

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN74116743
Enrollment
Unknown
Registered
2003-09-12
Start date
2002-02-20
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nutritional, Metabolic, Endocrine: Obesity Nutritional, Metabolic, Endocrine Obesity

Interventions

After medical and dietetic assessment, patients will receive a VLC diet (approx 700 cal) for no more than 3 months until 10 kg or 12% weight loss is achieved. Patients will be randomised to either 'Pu

Sponsors

Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with type 2 diabetes attending the Jenny O'Neill Diabetes Centre and patients attending Primary Care diabetes clinics 2. Who are overweight (Body Mass Index [BMI] >28) 3. Who are either on maximal or near maximal doses of oral hypoglycaemics or are insulin treated but have poor control (HbA1c >7.59) and are motivated to lose weight

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

MeasureTime frame
1. Weight loss, improvement of cardiovascular risk 2. Improvement of blood pressure (BP) 3. Improvement of psychological outcome—

Secondary

MeasureTime frame
Not provided at time of registration—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026